Dr. Agarwal's Eye Hospital Limited (NSE:DRAGARWQ)

Market Cap	24.89B +25.4%
Revenue (ttm)	4.77B +20.0%
Net Income	701.00M +28.3%
EPS	147.02 +26.4%
Shares Out	n/a
PE Ratio	35.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,826
Average Volume	1,054
Open	5,146.00
Previous Close	5,031.70
Day's Range	5,050.00 - 5,204.90
52-Week Range	4,600.00 - 6,059.70
Beta	n/a
RSI	64.93
Earnings Date	May 20, 2026

About NSE:DRAGARWQ

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrom...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1957
• Employees: 1,255
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DRAGARWQ

Financial Performance

In fiscal year 2026, NSE:DRAGARWQ's revenue was 4.77 billion, an increase of 20.03% compared to the previous year's 3.97 billion. Earnings were 701.00 million, an increase of 28.27%.